eHealth (EHTH) Panoramica del titolo
eHealth, Inc. gestisce un mercato di assicurazioni sanitarie che fornisce soluzioni per il coinvolgimento dei consumatori, l'educazione e l'iscrizione all'assicurazione sanitaria negli Stati Uniti. Maggiori dettagli
| Punteggio fiocco di neve | |
|---|---|
| Valutazione | 3/6 |
| Crescita futura | 0/6 |
| Prestazioni passate | 0/6 |
| Salute finanziaria | 4/6 |
| Dividendi | 0/6 |
Premi
Analisi del rischio
EHTH Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
Concorrenti di eHealth, Inc.
Storia dei prezzi e prestazioni
| Prezzi storici delle azioni | |
|---|---|
| Prezzo attuale dell'azione | US$1.76 |
| Massimo di 52 settimane | US$5.89 |
| Minimo di 52 settimane | US$1.20 |
| Beta | 1.57 |
| Variazione di 1 mese | -4.35% |
| Variazione a 3 mesi | 3.53% |
| Variazione di 1 anno | -60.18% |
| Variazione a 3 anni | -78.14% |
| Variazione a 5 anni | -97.30% |
| Variazione dall'IPO | -92.31% |
Notizie e aggiornamenti recenti
Aggiornamento della narrazione • May 06
EHTH: Softer 2026 Revenue Guide And Benefit Launch Will Shape Outlook
Narrative Update on eHealth Analysts have cut eHealth's average price target from about $5 to roughly $2, citing softer 2026 revenue expectations tied to reduced marketing spend by a major Medicare Advantage payor and cautious assumptions around the next annual enrollment period. Analyst Commentary Bearish analysts have moved quickly to reset expectations on eHealth, cutting price targets and shifting ratings to more neutral stances after the latest outlook.
Aggiornamento della narrazione • Apr 22
EHTH: Margin Discipline And New Offerings Will Reframe Long Term Prospects
Analysts have cut their price targets on eHealth significantly, with the consensus fair value moving from about $12.00 to roughly $3.00 as softer 2026 revenue guidance, reduced marketing spend from a major Medicare Advantage payor, and a tougher customer acquisition backdrop weigh on expectations. Analyst Commentary Recent Street research points to a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations after the 2026 revenue guide.Recent updates
Aggiornamento della narrazione • May 06
EHTH: Softer 2026 Revenue Guide And Benefit Launch Will Shape Outlook
Narrative Update on eHealth Analysts have cut eHealth's average price target from about $5 to roughly $2, citing softer 2026 revenue expectations tied to reduced marketing spend by a major Medicare Advantage payor and cautious assumptions around the next annual enrollment period. Analyst Commentary Bearish analysts have moved quickly to reset expectations on eHealth, cutting price targets and shifting ratings to more neutral stances after the latest outlook.Aggiornamento della narrazione • Apr 22
EHTH: Margin Discipline And New Offerings Will Reframe Long Term Prospects
Analysts have cut their price targets on eHealth significantly, with the consensus fair value moving from about $12.00 to roughly $3.00 as softer 2026 revenue guidance, reduced marketing spend from a major Medicare Advantage payor, and a tougher customer acquisition backdrop weigh on expectations. Analyst Commentary Recent Street research points to a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations after the 2026 revenue guide.
Aggiornamento della narrazione • Apr 07
EHTH: Conservative 2026 Guide And Marketing Pullback Will Support Margin Repair
Analysts have cut the average price target on eHealth to about $2 to $3 per share, down sharply from prior targets near $8 to $9. They cite softer 2026 revenue guidance tied to reduced marketing spend by a key Medicare Advantage payor, conservative assumptions for the next annual enrollment period, and a planned pullback in some customer acquisition channels.Aggiornamento della narrazione • Mar 24
EHTH: Conservative 2026 Revenue Guide Will Support Margin Focused Turnaround
Analysts have cut the average price target for eHealth by $1.50, citing softer than expected 2026 revenue guidance, reduced marketing spend by a major Medicare Advantage payor, and company plans to scale back certain customer acquisition channels while carriers remain focused on margins. Analyst Commentary Recent Street research reflects a more cautious stance on eHealth, with several firms cutting price targets and resetting expectations following the 2026 revenue guidance.Aggiornamento della narrazione • Mar 10
EHTH: Higher 2025 Earnings Guidance Will Support Margin Focused Turnaround
Analysts have sharply cut their average price target on eHealth from about $8.50 to roughly $3.75, reflecting lower $2 targets and a focus on weaker revenue expectations, along with an increased emphasis on margins and reduced customer acquisition spending. Analyst Commentary Recent research notes on eHealth highlight a meaningful reset in expectations, with price targets clustered around $2 and ratings largely at Hold.Aggiornamento della narrazione • Feb 24
EHTH: Higher 2025 Earnings Guidance Will Support Future Performance
Analysts have modestly adjusted their price target on eHealth to reflect a slightly higher discount rate and a small change in the assumed future P/E multiple, while keeping fair value steady at $8.50 as they reassess risk and valuation inputs without new Street research catalysts. What's in the News eHealth updated its earnings guidance for the year ending December 31, 2025, with total revenue now expected in a range of $540.0 million to $560.0 million, compared with the prior range of $525.0 million to $565.0 million (Key Developments).Articolo di analisi • Feb 10
Market Cool On eHealth, Inc.'s (NASDAQ:EHTH) Revenues Pushing Shares 48% Lower
The eHealth, Inc. ( NASDAQ:EHTH ) share price has fared very poorly over the last month, falling by a substantial 48...Aggiornamento della narrazione • Feb 09
EHTH: Enrollment Strength And Softer Competition Will Support Future Performance
Analysts have trimmed their price target on eHealth to US$9 from US$10, citing price adjustments even as the annual enrollment period tracks in line with expectations, supported by solid consumer demand and early signs of a more favorable competitive backdrop. Analyst Commentary Bullish Takeaways Bullish analysts point to the annual enrollment period tracking in line with internal expectations, which they see as a sign that execution is holding up against current industry conditions.Aggiornamento della narrazione • Jan 26
EHTH: Solid Enrollment Trends And Easing Competition Will Support Future Margins
Analysts have trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, along with signs of steady consumer demand and a somewhat more favorable competitive backdrop. Analyst Commentary Recent commentary around the price target cut frames eHealth as a company where execution looks generally on track, but with a valuation reset to reflect a more balanced risk and reward profile.Aggiornamento della narrazione • Jan 11
EHTH: Solid Enrollment Trends And Healthier Competition Will Support Margin Expansion
Analysts trimmed their price target on eHealth to US$9 from US$10, citing annual enrollment trends that are tracking in line with expectations, solid consumer demand on the platform, and early indications of a more favorable competitive environment. Analyst Commentary Analysts see a mixed picture for eHealth at the current US$9 price target, with solid execution on core drivers balanced against questions on how much upside is justified in the near term.Aggiornamento della narrazione • Dec 24
EHTH: Strengthening Enrollment Trends Will Support Future Margin Expansion Potential
Analysts have trimmed their price target on eHealth from $10.00 to $9.00 per share, citing in-line annual enrollment trends supported by strong platform demand and early signs of a more favorable competitive environment. Analyst Commentary Bullish Takeaways Bullish analysts highlight that the annual enrollment period is progressing in line with internal expectations, reinforcing confidence in management’s guidance and execution.Articolo di analisi • Dec 19
Further Upside For eHealth, Inc. (NASDAQ:EHTH) Shares Could Introduce Price Risks After 35% Bounce
eHealth, Inc. ( NASDAQ:EHTH ) shareholders would be excited to see that the share price has had a great month, posting...Aggiornamento della narrazione • Dec 10
EHTH: Improving Enrollment Dynamics Will Support Future Upside Potential
Analysts have trimmed their price target on eHealth to $9 from $10, citing an annual enrollment period that is tracking in line with expectations, supported by solid consumer demand and a gradually improving competitive landscape. Analyst Commentary Analysts view the latest price target revision as a reflection of balanced expectations for eHealth, incorporating both the progress made in the current enrollment cycle and the lingering execution and competitive risks that could affect future growth and valuation.Aggiornamento della narrazione • Nov 26
EHTH: Future Enrollment Trends Will Support Further Upside Potential
Narrative Update on eHealth: Analyst Price Target Revised Analysts have slightly reduced their price target for eHealth, lowering it from $8.75 to $8.50. This revision is due to a modest decrease in revenue growth outlook and a marginally higher discount rate.Aggiornamento della narrazione • Nov 12
EHTH: Future Profit Margins Will Drive Upside Despite Consumer Confusion
Analysts have revised their price target for eHealth down from $9.25 to $8.75. They cite a significant reduction in projected profit margin, even though revenue growth forecasts have slightly improved and the estimated future price-to-earnings ratio is notably higher.Seeking Alpha • Nov 08
eHealth: Undervalued And Gaining Momentum After Q3 Earnings Beat
Summary eHealth Inc. is positioned for a turnaround, leveraging digital platform enhancements, cost optimization, and strong insurer partnerships. EHTH trades at a deep discount to peers despite improved financials, nearly debt-free balance sheet, and superior liquidity and margins. Key risks include seasonality, regulatory changes, and competition, but Q3 earnings and open enrollment are positive signs of a turnaround. We rate EHTH a BUY, expecting a rebound to tangible book value ($14-$18/share) if FY25 guidance is met or exceeded. Read the full article on Seeking AlphaArticolo di analisi • Oct 28
eHealth, Inc. (NASDAQ:EHTH) Held Back By Insufficient Growth Even After Shares Climb 34%
Despite an already strong run, eHealth, Inc. ( NASDAQ:EHTH ) shares have been powering on, with a gain of 34% in the...Articolo di analisi • Sep 03
eHealth, Inc. (NASDAQ:EHTH) Surges 26% Yet Its Low P/S Is No Reason For Excitement
Those holding eHealth, Inc. ( NASDAQ:EHTH ) shares would be relieved that the share price has rebounded 26% in the last...Articolo di analisi • Aug 09
The eHealth, Inc. (NASDAQ:EHTH) Second-Quarter Results Are Out And Analysts Have Published New Forecasts
NasdaqGS:EHTH 1 Year Share Price vs Fair Value Explore eHealth's Fair Values from the Community and select yours...Articolo di analisi • May 15
eHealth, Inc.'s (NASDAQ:EHTH) 26% Dip In Price Shows Sentiment Is Matching Revenues
Unfortunately for some shareholders, the eHealth, Inc. ( NASDAQ:EHTH ) share price has dived 26% in the last thirty...
Nuova narrazione • Mar 31
Medicare Focus And AI Projects Will Improve Operations
Revenue and earnings growth driven by increased Medicare submissions, marketing investments, and enhanced enrollment margins.Articolo di analisi • Mar 16
Benign Growth For eHealth, Inc. (NASDAQ:EHTH) Underpins Stock's 30% Plummet
The eHealth, Inc. ( NASDAQ:EHTH ) share price has softened a substantial 30% over the previous 30 days, handing back...Seeking Alpha • Feb 26
eHealth: Another Big Run, Lock In, And Run House Money
Summary eHealth, Inc. was recommended at $6.78; now, with current gains to above $9, we suggest you lock in profits and hold EHTH stock for long-term growth. eHealth showed strong Q4 performance, but it was an outlier. We like EHTH shares for long-term exposure, but 2025 at best looks flat from 2024. Consider a house position after the rapid-return trade. Read the full article on Seeking AlphaArticolo di analisi • Dec 23
Market Might Still Lack Some Conviction On eHealth, Inc. (NASDAQ:EHTH) Even After 66% Share Price Boost
eHealth, Inc. ( NASDAQ:EHTH ) shares have continued their recent momentum with a 66% gain in the last month alone. Not...Seeking Alpha • Dec 17
Bull Run For EHealth, Inc.: Stock Flying On Solid Enrollment
Summary eHealth, Inc. is an online health insurance marketplace with strong enrollment, particularly in Medicare plans, aided by new technologies and live assistance. Despite a 90%+ drop from its 2020 peak, Q3 2024 showed signs of improvement, with a 16% decline in acquisition costs and a 6% reduction in adjusted net loss. Significant growth in submitted Medicare applications and a new member retention program have led to raised revenue and profit guidance for 2024. EHTH stock, is likely heading to double digits in 2025, driven by improved outlook and retention strategies. Read the full article on Seeking AlphaArticolo di analisi • Nov 08
A Piece Of The Puzzle Missing From eHealth, Inc.'s (NASDAQ:EHTH) 31% Share Price Climb
The eHealth, Inc. ( NASDAQ:EHTH ) share price has done very well over the last month, posting an excellent gain of 31...Articolo di analisi • Aug 30
Positive Sentiment Still Eludes eHealth, Inc. (NASDAQ:EHTH) Following 25% Share Price Slump
To the annoyance of some shareholders, eHealth, Inc. ( NASDAQ:EHTH ) shares are down a considerable 25% in the last...Rendimenti per gli azionisti
| EHTH | US Insurance | US Mercato | |
|---|---|---|---|
| 7D | -6.9% | 0.9% | -0.3% |
| 1Y | -60.2% | -10.5% | 24.0% |
Ritorno vs Industria: EHTH ha avuto una performance inferiore rispetto al US Insurance che ha registrato un rendimento -10.5 % nell'ultimo anno.
Rendimento vs Mercato: EHTH ha avuto una performance inferiore al mercato US che ha registrato un rendimento 24 % nell'ultimo anno.
Volatilità dei prezzi
| EHTH volatility | |
|---|---|
| EHTH Average Weekly Movement | 16.3% |
| Insurance Industry Average Movement | 4.3% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in US Market | 16.2% |
| 10% least volatile stocks in US Market | 3.1% |
Prezzo delle azioni stabile: Negli ultimi 3 mesi il prezzo delle azioni di EHTH è stato volatile rispetto al mercato US.
Volatilità nel tempo: La volatilità settimanale ( 16% ) di EHTH è rimasta stabile nell'ultimo anno, ma è comunque superiore al 75% delle azioni US.
Informazioni sull'azienda
| Fondato | I dipendenti | AMMINISTRATORE DELEGATO | Sito web |
|---|---|---|---|
| 1997 | 1,665 | Derrick Duke | www.ehealthinsurance.com |
eHealth, Inc. gestisce un mercato di assicurazioni sanitarie che fornisce soluzioni per il coinvolgimento dei consumatori, l'educazione e l'iscrizione all'assicurazione sanitaria negli Stati Uniti. Opera in due segmenti: Medicare e Datori di lavoro e Individuali. Il segmento Medicare offre la vendita di piani di assicurazione sanitaria legati a Medicare, come Medicare Advantage, Medicare Supplement e Medicare Part D per i beneficiari di Medicare, tra cui, ma non solo, assicurazioni dentistiche e visive e piani di indennità ospedaliera, oltre a programmi pubblicitari per il marketing e altri servizi.
eHealth, Inc. Riepilogo dei fondamenti
| EHTH statistiche fondamentali | |
|---|---|
| Capitalizzazione di mercato | US$55.86m |
| Utili (TTM) | -US$18.54m |
| Ricavi(TTM) | US$528.91m |
0.1x
Rapporto P/S-3.0x
Rapporto P/EEHTH è sopravvalutato?
Vedi Fair Value e analisi di valutazioneUtili e ricavi
| EHTH Conto economico (TTM) | |
|---|---|
| Ricavi | US$528.91m |
| Costo del fatturato | US$0 |
| Profitto lordo | US$528.91m |
| Altre spese | US$547.45m |
| Utili | -US$18.54m |
Ultimi utili riportati
Mar 31, 2026
Prossima data di guadagno
n/a
| Utile per azione (EPS) | -0.58 |
| Margine lordo | 100.00% |
| Margine di profitto netto | -3.51% |
| Rapporto debito/patrimonio netto | 11.7% |
Come si è comportato EHTH nel lungo periodo?
Vedi performance storica e confrontoAnalisi aziendale e situazione dei dati finanziari
| Dati | Ultimo aggiornamento (ora UTC) |
|---|---|
| Analisi dell'azienda | 2026/05/17 23:46 |
| Prezzo dell'azione a fine giornata | 2026/05/15 00:00 |
| Utili | 2026/03/31 |
| Utili annuali | 2025/12/31 |
Fonti dei dati
I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.
| Pacchetto | Dati | Tempistica | Esempio Fonte USA * |
|---|---|---|---|
| Dati finanziari della società | 10 anni |
| |
| Stime di consenso degli analisti | +3 anni |
|
|
| Prezzi di mercato | 30 anni |
| |
| Proprietà | 10 anni |
| |
| Gestione | 10 anni |
| |
| Sviluppi principali | 10 anni |
|
* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.
Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.
Modello di analisi e Snowflake
I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina Github; abbiamo anche guide su come utilizzare i nostri report e tutorial su Youtube.
Scoprite il team di livello mondiale che ha progettato e realizzato il modello di analisi Simply Wall St.
Metriche di settore e industriali
Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.
Fonti analitiche
eHealth, Inc. è coperta da 25 analisti. 5 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.
| Analista | Istituzione |
|---|---|
| Steven Valiquette | Barclays |
| Steven Valiquette | Barclays |
| Nathaniel Schindler | BofA Global Research |